{Reference Type}: Journal Article
{Title}: Considerations for Imaging of Malignant Pleural Mesothelioma: A Consensus Statement from the International Mesothelioma Interest Group.
{Author}: Katz SI;Straus CM;Roshkovan L;Blyth KG;Frauenfelder T;Gill RR;Lalezari F;Erasmus J;Nowak AK;Gerbaudo VH;Francis RJ;Armato SG;
{Journal}: J Thorac Oncol
{Volume}: 18
{Issue}: 3
{Year}: 03 2023
{Factor}: 20.121
{DOI}: 10.1016/j.jtho.2022.11.018
{Abstract}: Malignant pleural mesothelioma (MPM) is an aggressive primary malignancy of the pleura that presents unique radiologic challenges with regard to accurate and reproducible assessment of disease extent at staging and follow-up imaging. By optimizing and harmonizing technical approaches to imaging MPM, the best quality imaging can be achieved for individual patient care, clinical trials, and imaging research. This consensus statement represents agreement on harmonized, standard practices for routine multimodality imaging of MPM, including radiography, computed tomography, 18F-2-deoxy-D-glucose positron emission tomography, and magnetic resonance imaging, by an international panel of experts in the field of pleural imaging assembled by the International Mesothelioma Interest Group. In addition, modality-specific technical considerations and future directions are discussed. A bulleted summary of all technical recommendations is provided.